Company Overview of Novo A/S
Novo A/S is a private equity and venture capital arm of The Novo Nordisk Foundation specializing in direct and secondary direct investments. Within direct, it seeks to make private equity and venture capital investments in development stage companies in the form of seed, start up, early venture, mid venture, late venture, growth equity, mature, later stage, and mezzanine investments. It also provides pre-seed grants for early stage projects. The firm seeks to invest in biotechnology, healthcare, and life sciences companies with a focus on investments in products for diagnosis, control, treatment, and prevention of disease; development and application of biotechnology; instruments and medical...
Tuborg Havnevej 19
Founded in 1999
Key Executives for Novo A/S
Compensation as of Fiscal Year 2014.
Novo A/S Key Developments
Novo A/S Presents at 2014 Asia Biotech Invest Conference, Jun-03-2014 through Jun-05-2014
Jun 2 14
Novo A/S Presents at 2014 Asia Biotech Invest Conference, Jun-03-2014 through Jun-05-2014. Venue: Sheraton Hong Kong Hotel & Towers, 20 Nathan Road, Kowloon, Hong Kong. Presentation Date & Speakers: Jun-04-2014, Eric Shiozaki, Principal. Jun-05-2014, Eric Shiozaki, Principal.
Novo A/S Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-13-2014 11:50 AM
Mar 21 14
Novo A/S Presents at BioTrinity 2014 - European Biopartnering and Investment Conference, May-13-2014 11:50 AM. Venue: London, United Kingdom. Speakers: Martin W. Edwards, Senior Partner.
Novo A/S Presents at Sachs Annual Biotech in Europe Investor Forum, Sep-30-2013 12:10 PM
Sep 24 13
Novo A/S Presents at Sachs Annual Biotech in Europe Investor Forum, Sep-30-2013 12:10 PM. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152, Zurich, Switzerland. Speakers: Nanna Luneborg, Investment Director, Novo Seeds.
Similar Private Companies By Industry
Recent Private Companies Transactions